Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong · Delayed Price · Currency is HKD 64.60
+12.50 (23.99%)
Jul 21, 2026, 3:11 PM HKT
Vigonvita Life Sciences Market Cap
Vigonvita Life Sciences has a market cap or net worth of 8.73 billion as of July 20, 2026.
Market Cap
8.73B
Enterprise Value
8.86B
Revenue
113.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
64.60
ChartMarket Cap Chart
Since November 6, 2025, Vigonvita Life Sciences's market cap has decreased from 13.74B to 8.73B, a decrease of -36.46%. That is a compound annual growth rate of -47.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 8.73B | -36.35% |
| Dec 31, 2025 | 13.72B | -0.18% |
| Nov 6, 2025 | 13.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 270.72B |
| Hansoh Pharmaceutical Group Company | 200.44B |
| Innovent Biologics | 161.04B |
| WuXi Biologics | 157.01B |
| Shandong Xinhua Pharmaceutical Company | 9.13B |
| Everest Medicines | 9.09B |
| TenNor Therapeutics (Suzhou) | 8.94B |
| CARsgen Therapeutics Holdings | 8.91B |